-
At a Sarasota news conference, Attorney General Ashley Moody says xylazine is being mixed with other, more common illegal drugs, and being sold to unsuspecting users.
-
Florida lawmakers are moving forward with a bipartisan plan to regulate the use of kratom, an herbal supplement that causes opioid- and stimulant-like effects.
-
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
-
Ashley Moody is warning parents about the opioid after an alarming report found that children younger than 14 are dying of fentanyl poisoning at a faster rate than any other age group.
-
Psychedelic drugs were a hot topic at this year's Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD.
-
Colorado, New Hampshire and New Mexico are also seeking federal permission to import cost-lowering prescription drugs from Canada. President Joe Biden endorsed the approach in his 2020 campaign but has yet to approve any state plan.
-
The Biden administration will use data from EMS first responders to track overdoses. The focus will be on improving response to a public health crisis that kills more than 100,000 Americans annually.
-
Health justice lawyer Priti Krishtel doesn't believe your ability to heal should depend on your ability to pay. Her mission is to reform the patent system that drug companies use to block competition.
-
The Drug Enforcement Administration is warning that drug dealers are marketing rainbow-colored fentanyl to kids. Many drug experts say that's likely not happening.
-
Like fentanyl, eutylone is often mixed with other drugs so people don't realize they're taking it until it's too late.
-
Cigarette use has been declining for decades, while marijuana use has been on the rise, according to a new Gallup survey in the U.S.
-
The National Institutes of Health annually surveys substance abuse among young adults in its Monitoring the Future study.